Famotidine Powder, For Suspension
Product Images NDC 60219-2090

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 60219-2090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Famotidine For Oral Suspension 1)

Chemical structure of the active ingredient famotidine, showing its molecular arrangement including sulfur, nitrogen, oxygen, and carbon atoms with associated functional groups.*

FDA Label Image

3 (Famotidine For Oral Suspension 2)

Label for Famotidine oral suspension USP 40 mg/5 mL powder for suspension, 50 mL bottle, by Amneal Pharmaceuticals NY LLC. It contains 400 mg famotidine per 50 mL when reconstituted. Directions include shaking well before use and storage instructions. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, with distribution in Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.